Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AQST compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
AQST
Aquestive Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
AQST
Aquestive Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AQST
12
INDV
Indivior
customer
—
Licensees
unlisted
customer
—
RTW Investments
unlisted
customer
—
Sunovion
unlisted
customer
8 more · AQST chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
AQST
Aquestive Therapeutics, Inc.
Change
3.64
· pre 3.64
· delayed
Mkt cap
$460.0M
Revenue
$8M
Q3 FY26
Revenue
$45M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,349.95
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
AQST
Aquestive Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
3.64
pre 3.64
delayed
Price
1,371.32
pre 1,349.95
delayed
$460.0M
Mkt cap
$1.2T
Q3 FY26
$8M
Revenue
$24.4B
Q3 FY26
FY25
$45M
Revenue
$65.2B
FY25
Change
Change
AQST
3.64
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed